March 31, 2026 · Form 4 insider transaction
Karydas Daphne bought 3,000 shares of Mineralys Therapeutics, Inc. at $12.02 per share, a transaction worth $36.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025.